Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo

Alon Herschhorn

doi:10.1021/acsinfecdis.2c00573

Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo

Alon Herschhorn

Medicine - Infectious Disease and International

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	5-8
Number of pages	4
Journal	ACS Infectious Diseases
Volume	9
Issue number	1
DOIs	https://doi.org/10.1021/acsinfecdis.2c00573
State	Published - Jan 13 2023

Bibliographical note

Funding Information:
I thank Joseph Sodroski (Dana-Farber Cancer Institute/Harvard Medical School) and John Mascola (NIH/NIAID Vaccine Research Center) for reading the manuscript and providing helpful comments. This work was supported by NIH U01 grant 1U01AI169587 to Alon Herschhorn (contact PI), Brandon Dekosky, Priyamvada Acharya, and Max Crispin.

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1021/acsinfecdis.2c00573

OpenUrl availability

Full text

Cite this

@article{5b17c38284124f2e87852bc8f0081620,

title = "Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo",

author = "Alon Herschhorn",

note = "Funding Information: I thank Joseph Sodroski (Dana-Farber Cancer Institute/Harvard Medical School) and John Mascola (NIH/NIAID Vaccine Research Center) for reading the manuscript and providing helpful comments. This work was supported by NIH U01 grant 1U01AI169587 to Alon Herschhorn (contact PI), Brandon Dekosky, Priyamvada Acharya, and Max Crispin.",

year = "2023",

month = jan,

day = "13",

doi = "10.1021/acsinfecdis.2c00573",

language = "English (US)",

volume = "9",

pages = "5--8",

journal = "ACS Infectious Diseases",

issn = "2373-8227",

publisher = "American Chemical Society",

number = "1",

}

TY - JOUR

T1 - Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo

AU - Herschhorn, Alon

N1 - Funding Information: I thank Joseph Sodroski (Dana-Farber Cancer Institute/Harvard Medical School) and John Mascola (NIH/NIAID Vaccine Research Center) for reading the manuscript and providing helpful comments. This work was supported by NIH U01 grant 1U01AI169587 to Alon Herschhorn (contact PI), Brandon Dekosky, Priyamvada Acharya, and Max Crispin.

PY - 2023/1/13

Y1 - 2023/1/13

UR - http://www.scopus.com/inward/record.url?scp=85143978762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143978762&partnerID=8YFLogxK

U2 - 10.1021/acsinfecdis.2c00573

DO - 10.1021/acsinfecdis.2c00573

M3 - Short survey

C2 - 36512322

AN - SCOPUS:85143978762

SN - 2373-8227

VL - 9

SP - 5

EP - 8

JO - ACS Infectious Diseases

JF - ACS Infectious Diseases

IS - 1

ER -

Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo

Bibliographical note

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this